You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 13, 2024

CLINICAL TRIALS PROFILE FOR LINACLOTIDE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LINACLOTIDE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00402337 ↗	Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation	Completed	Ironwood Pharmaceuticals, Inc.	Phase 2	2006-11-01	The primary purpose of this study is to evaluate the efficacy and safety of administration of linaclotide acetate in patients with chronic constipation.
NCT00460811 ↗	Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)	Completed	Ironwood Pharmaceuticals, Inc.	Phase 2	2007-04-01	The purpose of this study is to determine the safety, efficacy, and dose response of a range of oral doses of linaclotide administered to patients meeting criteria for IBS-C.
NCT00730015 ↗	Trial of Linaclotide in Patients With Chronic Constipation	Completed	Forest Laboratories	Phase 3	2008-08-01	The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with chronic constipation (CC). The primary efficacy parameter is the percentage of patients in each dosing group that meet the protocol definition for Complete Spontaneous Bowel Movement (CSBM) Overall Responder.
NCT00730015 ↗	Trial of Linaclotide in Patients With Chronic Constipation	Completed	Ironwood Pharmaceuticals, Inc.	Phase 3	2008-08-01	The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with chronic constipation (CC). The primary efficacy parameter is the percentage of patients in each dosing group that meet the protocol definition for Complete Spontaneous Bowel Movement (CSBM) Overall Responder.
NCT00730171 ↗	An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation	Completed	Forest Laboratories	Phase 3	2008-09-01	The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).
NCT00730171 ↗	An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation	Completed	Ironwood Pharmaceuticals, Inc.	Phase 3	2008-09-01	The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LINACLOTIDE

Condition Name

Chart
Table

Condition Name for LINACLOTIDE
Intervention	Trials
Irritable Bowel Syndrome With Constipation	9
Chronic Constipation	9
Functional Constipation	4
Chronic Idiopathic Constipation	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LINACLOTIDE
Intervention	Trials
Constipation	34
Irritable Bowel Syndrome	19
Syndrome	17
Colorectal Neoplasms	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LINACLOTIDE

Trials by Country

Map
Table

Trials by Country for LINACLOTIDE
Location	Trials
United States	619
Canada	22
United Kingdom	13
Bulgaria	7
China	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LINACLOTIDE
Location	Trials
Texas	23
Virginia	22
Pennsylvania	22
Florida	22
California	22
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LINACLOTIDE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LINACLOTIDE
Clinical Trial Phase	Trials
Phase 4	5
Phase 3	16
Phase 2	11
[disabled in preview]	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LINACLOTIDE
Clinical Trial Phase	Trials
Completed	27
Recruiting	6
Not yet recruiting	5
[disabled in preview]	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LINACLOTIDE

Sponsor Name

Chart
Table

Sponsor Name for LINACLOTIDE
Sponsor	Trials
Ironwood Pharmaceuticals, Inc.	23
Forest Laboratories	15
Astellas Pharma Inc	6
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LINACLOTIDE
Sponsor	Trials
Industry	54
Other	39
NIH	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.